PrimeRFP SCOUT · Federal Contract Recompete Brief

HT941023F0002APTIMA COMBO 2 ASSAY (ct gc) — Gen-Probe Inc

Gen-Probe Inc holds $112.5M across 5,120 federal awards. This PIID sits alongside 3 related awards under parent N6264519D5014. PoP ended Jul 7, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Defense Health Agency

Awarding office

Gen-Probe Inc

Recipient

Jul 7, 2023

PoP end

$372K

Obligated

$372K

Potential

334516

NAICS

6525

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Gen-Probe Inc — $90

Contract facts

Federal

Contract numberHT941023F0002

Also listed asHT9410-23-F-0002

Also listed asN6264519D5014-HT941023F0002

AgencyDefense Health Agency

Awarding officeDefense Health Agency

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentGen-Probe Inc

CAGE0BDV3

UEIQNXWLAJDL4J3

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6525

Parent IDIQ / IDVN6264519D5014

Place of performanceSAN DIEGO CA

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startOct 12, 2022

PoP end (current)Jul 7, 2023

Obligated$372K

Current value$372K

Potential value$372K

APTIMA COMBO 2 ASSAY (CT/GC) TESTING FOR NAVAL MEDICAL CENTER SAN DIEGO is a federal award for Defense Health Agency held by Gen-Probe Inc. Estimated value $372K ($372K obligated). Current period of performance ends Jul 7, 2023. Place of performance: SAN DIEGO CA.

APTIMA COMBO 2 ASSAY (CT/GC) TESTING FOR NAVAL MEDICAL CENTER SAN DIEGO

Recompete timing

Public

● Past PoP end (1141 days ago)

Current PoP ended Jul 7, 2023 (1141 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Gen-Probe Inc — $112.5M obligated across 5,120 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$719K · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

W81K0222P0032

NUCLEIC ACID ACTIVE REAGENTS AND ASSAY KITS FOR PANTHER AND FUSION INSTRUMENTS FOR TAMC 03…

$2.0M

Sep 30, 2026

N3239822P0303

EXERCISE OPTION YEAR 4 SERVICE AGREEMENT N3239822P0303 FOR: PANTHER FUSION (SN: 2090003912…

$122K

May 19, 2027

W81K0022P0111

KIT, APTIMA COMBO 2 CT/GC 250 TEST

$2.2M

Sep 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HT941023F0002?

HT941023F0002 (APTIMA COMBO 2 ASSAY (ct gc)) is a Defense Health Agency award with a potential value of $372K, currently held by Gen-Probe Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT9410-23-F-0002?

HT9410-23-F-0002 is the dashed form of PIID HT941023F0002 (APTIMA COMBO 2 ASSAY (ct gc)), held by Gen-Probe Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT941023F0002?

Defense Health Agency awarded HT941023F0002 to Gen-Probe Inc (potential $372K).

Who is the incumbent on HT941023F0002?

Gen-Probe Inc is the incumbent with $112.5M across 5120 related awards in SCOUT’s public footprint. The current period of performance ends Jul 7, 2023.

When does Gen-Probe Inc’s HT941023F0002 come up for recompete?

SCOUT tracks a period-of-performance end of Jul 7, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Apr 12, 2023